BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33016802)

  • 21. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children.
    Kerur B; Machan JT; Shapiro JM; Cerezo CS; Markowitz J; Mack DR; Griffiths AM; Otley AR; Pfefferkorn MD; Rosh JR; Keljo DJ; Boyle B; Oliva-Hemker M; Kay MH; Saeed SA; Grossman AB; Sudel B; Kappelman MD; Schaefer M; Tomer G; Bousvaros A; Lerer T; Hyams JS; LeLeiko NS
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1467-1473. PubMed ID: 29486253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of children with mild Crohn's disease.
    Sharma Y; Bousvaros A; Liu E; Bender Stern J
    World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
    Toh JWT; Wang N; Young CJ; Rickard MJFX; Keshava A; Stewart P; Kariyawasam V; Leong R;
    Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
    Nuti F; Civitelli F; Bloise S; Oliva S; Aloi M; Latorre G; Viola F; Cucchiara S
    J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of pediatric Crohn's disease: a population-based cohort study.
    Vernier-Massouille G; Balde M; Salleron J; Turck D; Dupas JL; Mouterde O; Merle V; Salomez JL; Branche J; Marti R; Lerebours E; Cortot A; Gower-Rousseau C; Colombel JF
    Gastroenterology; 2008 Oct; 135(4):1106-13. PubMed ID: 18692056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
    Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors that determine risk for surgery in pediatric patients with Crohn's disease.
    Schaefer ME; Machan JT; Kawatu D; Langton CR; Markowitz J; Crandall W; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo DJ; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Kappelman MD; Saeed SA; Hyams JS; Leleiko NS
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):789-94. PubMed ID: 20566311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
    Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
    Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
    Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery, Crohn's disease, and the biological era: has there been an impact?
    Slattery E; Keegan D; Hyland J; O'donoghue D; Mulcahy HE
    J Clin Gastroenterol; 2011 Sep; 45(8):691-3. PubMed ID: 21135702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
    J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.
    Eberhardson M; Söderling JK; Neovius M; Cars T; Myrelid P; Ludvigsson JF; Askling J; Ekbom A; Olén O
    Aliment Pharmacol Ther; 2017 Sep; 46(6):589-598. PubMed ID: 28752637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
    Rungoe C; Langholz E; Andersson M; Basit S; Nielsen NM; Wohlfahrt J; Jess T
    Gut; 2014 Oct; 63(10):1607-16. PubMed ID: 24056767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
    Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
    J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
    Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.